EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases

Tiantian Zheng iD, Chenchen Meng iD, Zhengtian Lv iD, Chenxia Wu iD, Xinbin Zhou iD, Wei Mao iD

Reviews in Cardiovascular Medicine · 20.03.2025 · 26 (3)

DOI: 10.31083/rcm26740 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 20.03.2025. Verfasst von Tiantian Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the continued aging of the global population, cardiovascular diseases (CVDs) remain the main cause of death worldwide, with millions of fatalities from diseases, including stroke and coronary artery disease, reported annually. Thus, novel therapeutic approaches and targets are urgently required for diagnosing and treating CVDs. Recent studies emphasize the vital part of gut microbiota in both CVD prevention and management. Among these, Faecalibacterium prausnitzii (F. prausnitzii) has emerged as a promising probiotic capable of improving intestinal health. Although preliminary investigations demonstrate that F. prausnitzii positively enhances cardiovascular health, research specifically connecting this strain to CVD outcomes remains limited. Based on current research and assessment of possible clinical applications, this paper aimed to investigate the positive effects on cardiovascular health using F. prausnitzii and its metabolites. Targeting gut flora is expected to become a mainstay in CVD treatment as research develops.

Schlagwörter

Stichwörter der Autor:innen

Faecalibacterium prausnitzicardiovascular diseasesgut microbiomes

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China.
  • Department of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, 310030 Hangzhou, Zhejiang, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310006 Hangzhou, Zhejiang, China.
  • Zhejiang Key Laboratory of Integrative Chinese and Western Medicine for Diagnosis and Treatment of Circulatory Diseases, 310030 Hangzhou, Zhejiang, China.

ORCID-Profile: Tiantian Zheng, Chenchen Meng, Zhengtian Lv, Chenxia Wu, Xinbin Zhou, Wei Mao

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine

Zitieren

APA

Zheng, T., Meng, C., Lv, Z., Wu, C., Zhou, X., & Mao, W. (2025). The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases. Reviews in Cardiovascular Medicine, 26(3). https://doi.org/10.31083/rcm26740

Vancouver

Zheng T, Meng C, Lv Z, Wu C, Zhou X, Mao W. The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases. Reviews in Cardiovascular Medicine. 2025;26(3). doi:10.31083/rcm26740

BibTeX
@article{Zheng2025,
  author = {Zheng, Tiantian and Meng, Chenchen and Lv, Zhengtian and Wu, Chenxia and Zhou, Xinbin and Mao, Wei},
  title = {The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2025},
  volume = {26},
  number = {3},
  doi = {10.31083/rcm26740}
}
Kostenlos starten →